Reviewed By
Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.6
USERS' SCORE
Good
Based on 11 Reviews
8
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Ginkgo Extract (Ginkgo biloba) (leaf) (50:1 Standardized Extract, Min. 24%Ginkgoflavonglycosides and 6% Terpene Lactones)
120 mg
**
Organic Eleuthero (Eleutherococcus senticosus) (Root)
250 mg
**
Top Medical Research Studies
8
We examined the effectiveness of a special ginkgo extract, known as EGb 761, in managing vertigo. The study involved rigorous methods, including randomized, double-blind, and placebo-controlled trials, ensuring that the results are reliable and valid.
Our review showcased various experimental and clinical studies focusing on how EGb 761 impacts vestibular compensation—the process that helps our brain adjust to balance and spatial orientation challenges. These studies demonstrated a beneficial effect of the extract in enhancing vestibular compensation both in animals and humans.
Thus, we can confidently say that the evidence supports the efficacy of EGb 761 in treating vertiginous syndromes. This makes ginkgo extract a promising option for individuals who suffer from different types of vertigo.
Our review showcased various experimental and clinical studies focusing on how EGb 761 impacts vestibular compensation—the process that helps our brain adjust to balance and spatial orientation challenges. These studies demonstrated a beneficial effect of the extract in enhancing vestibular compensation both in animals and humans.
Thus, we can confidently say that the evidence supports the efficacy of EGb 761 in treating vertiginous syndromes. This makes ginkgo extract a promising option for individuals who suffer from different types of vertigo.
Read More
8
We conducted a study to compare the effectiveness and safety of Ginkgo biloba extract, known as EGb 761, with betahistine in treating patients suffering from vertigo. In this clinical trial, 160 patients, averaging 58 years old, were split into two groups. One group received EGb 761 at a dosage of 240 mg per day, while the other group was given betahistine at 32 mg per day, both over a span of 12 weeks.
Throughout the treatment period, we utilized various measures to assess the patients' symptoms, including an 11-point scale to gauge their level of vertigo. Both treatments showed improvement across all measures, and there were no statistically significant differences between the two groups regarding how well they responded to treatment. Interestingly, we noticed a trend where patients taking EGb 761 reported slightly better improvements.
In terms of tolerability, EGb 761 emerged as the more favorable option. There were 27 adverse events reported among 19 patients taking Ginkgo biloba, compared to 39 adverse incidents in 31 patients taking betahistine. Overall, both treatments were similarly effective, but EGb 761 was better tolerated, making it a promising alternative for patients dealing with vertigo.
Throughout the treatment period, we utilized various measures to assess the patients' symptoms, including an 11-point scale to gauge their level of vertigo. Both treatments showed improvement across all measures, and there were no statistically significant differences between the two groups regarding how well they responded to treatment. Interestingly, we noticed a trend where patients taking EGb 761 reported slightly better improvements.
In terms of tolerability, EGb 761 emerged as the more favorable option. There were 27 adverse events reported among 19 patients taking Ginkgo biloba, compared to 39 adverse incidents in 31 patients taking betahistine. Overall, both treatments were similarly effective, but EGb 761 was better tolerated, making it a promising alternative for patients dealing with vertigo.
Read More
8
We conducted a study to explore the effectiveness of Ginkgo biloba for treating vertigo, a condition often experienced by the elderly. In this double-blinded, randomized clinical trial, we looked at 170 patients aged 60 to 80 who suffered from vertigo related to atherosclerosis. Half of the participants received Ginkgo biloba while the other half were treated with a homeopathic remedy called Vertigoheel.
After six weeks, we examined how both treatments affected the dizziness experienced by the participants. We discovered that both Ginkgo biloba and Vertigoheel led to significant improvements in dizziness scores. The participants reported reductions in dizziness intensity, frequency, and duration, with no noticeable difference in effectiveness between the two treatments.
Our results suggest that Vertigoheel is a viable option for individuals looking for alternatives to Ginkgo biloba in managing atherosclerosis-related vertigo. Importantly, patients tolerated both treatments well, indicating a promising avenue for symptom relief without significant side effects.
After six weeks, we examined how both treatments affected the dizziness experienced by the participants. We discovered that both Ginkgo biloba and Vertigoheel led to significant improvements in dizziness scores. The participants reported reductions in dizziness intensity, frequency, and duration, with no noticeable difference in effectiveness between the two treatments.
Our results suggest that Vertigoheel is a viable option for individuals looking for alternatives to Ginkgo biloba in managing atherosclerosis-related vertigo. Importantly, patients tolerated both treatments well, indicating a promising avenue for symptom relief without significant side effects.
Read More
Most Useful Reviews
9
Reduced dizziness
9 people found this helpful
Great for vertigo! My husband recently had his first (and hopefully last) vertigo attack, which landed him in the hospital. Being anti-medication, I researched natural supplements. I ordered Ginkgo Biloba and Ginger from NOW brand, as I trust them. He has been taking it daily for two weeks, and the dizziness has started to subside after a few days. This will now be part of his daily vitamin regimen.
Read More
9
Immediate vertigo relief
2 people found this helpful
I assure you this product is one of the best and provides immediate relief from inner ear vertigo and migraine pain while enhancing focus. I recommend it for both adults and children.
Read More
9
Stopped vertigo episodes
Since I started taking ginkgo daily, I no longer experience episodes of vertigo. It's been nine months now, and I highly recommend it.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.6
- All Researches
9
We conducted a robust study to evaluate how effective Ginkgo biloba extract, known as GBE50, is for treating dizziness related to cerebral arteriosclerosis. This involved a well-structured multi-center trial that was double-blind and randomized. We gathered 404 participants across ten hospitals in China, allowing us to compare results thoroughly.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
Read More
9
We conducted a randomized study involving 84 patients to evaluate the effects of Epley's maneuver, both alone and combined with certain medications, including Ginkgo biloba, on benign paroxysmal positional vertigo (BPPV). Participants were divided into two groups: one received only Epley's maneuver, while the other was treated with Epley's maneuver along with Betahistine mesilate, flunarizine hydrochloride, and Ginkgo biloba extract.
After just one week, we found that the group receiving Ginkgo along with Epley’s maneuver had a significantly higher cure rate (78.57% vs. 50.00%) and total effective rate (92.86% vs. 80.95%) compared to the control group. However, after four weeks, the difference in success rates between the two groups was not statistically significant.
Interestingly, when we looked at recurrence rates after six months, fewer patients in the group that used Ginkgo experienced a relapse of symptoms (7.14% vs. 16.67%), indicating that the combination therapy might be more effective in preventing future episodes. Overall, our findings suggest that Epley's maneuver, especially when paired with Ginkgo, is an effective treatment for vertigo that can potentially reduce recovery time and recurrence of symptoms.
After just one week, we found that the group receiving Ginkgo along with Epley’s maneuver had a significantly higher cure rate (78.57% vs. 50.00%) and total effective rate (92.86% vs. 80.95%) compared to the control group. However, after four weeks, the difference in success rates between the two groups was not statistically significant.
Interestingly, when we looked at recurrence rates after six months, fewer patients in the group that used Ginkgo experienced a relapse of symptoms (7.14% vs. 16.67%), indicating that the combination therapy might be more effective in preventing future episodes. Overall, our findings suggest that Epley's maneuver, especially when paired with Ginkgo, is an effective treatment for vertigo that can potentially reduce recovery time and recurrence of symptoms.
Read More
8
We explored how flunarizine, when combined with ginkgo leaf extract and dipyridamole injection, can impact hemorheology and improve symptoms of vertigo in elderly patients. The study involved 105 elderly participants with vertigo, dividing them into two groups: one receiving the combination treatment and the other receiving flunarizine alone.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
Read More
8
Ginkgo's impact on childhood vertigo
We explored the effectiveness of using ginkgo biloba in treating recurrent vertigo in children who have unilateral vestibular dysfunction but maintain normal balance. In a structured study, thirty children aged 4 to 13 were divided into groups to receive different treatments. While two groups received specific training—one with vestibulo-ocular reflex adaptation and another with Cawthorne-Cooksey training—the control group didn't undergo any training at all.
All participants were also given drops containing ginkgo biloba. The results indicated that the vestibular rehabilitation training notably improved vertigo symptoms. However, we were unable to isolate the specific effects of ginkgo from the training programs due to the study design.
Thus, while ginkgo was part of the treatment, the overall benefits of the training overshadowed any potential impacts it might have had on its own. It noted that children had a better acceptance of the VOR adaptation program compared to the classic Cawthorne-Cooksey training, pointing towards the potential importance of treatment experience in children.
All participants were also given drops containing ginkgo biloba. The results indicated that the vestibular rehabilitation training notably improved vertigo symptoms. However, we were unable to isolate the specific effects of ginkgo from the training programs due to the study design.
Thus, while ginkgo was part of the treatment, the overall benefits of the training overshadowed any potential impacts it might have had on its own. It noted that children had a better acceptance of the VOR adaptation program compared to the classic Cawthorne-Cooksey training, pointing towards the potential importance of treatment experience in children.
Read More
8
We explored the effectiveness of ginkgo extract, specifically EGb 761, in enhancing recovery from vestibular damage caused by unilateral inner ear impairment in a rat model. The study involved different groups of rats receiving varying doses of ginkgo for six weeks prior to and after a procedure simulating inner ear damage. Control groups were included to establish clear comparisons.
Our findings revealed that the rats receiving the highest dose of ginkgo (75 mg/kg) showed significant improvements in their vestibular function. Particularly, there was a notable reduction in symptoms like nystagmus and postural imbalance soon after the treatment, and these rats demonstrated increased mobility compared to control groups.
Lower doses also led to quicker recovery from postural asymmetry, although they didn't affect mobility as strongly. The study further indicated that ginkgo may influence brain activity, altering glucose metabolism in regions associated with balance and coordination. This suggests that ginkgo could support recovery following acute vestibular loss, encouraging us to consider its potential at higher dosages for vestibular compensation.
Our findings revealed that the rats receiving the highest dose of ginkgo (75 mg/kg) showed significant improvements in their vestibular function. Particularly, there was a notable reduction in symptoms like nystagmus and postural imbalance soon after the treatment, and these rats demonstrated increased mobility compared to control groups.
Lower doses also led to quicker recovery from postural asymmetry, although they didn't affect mobility as strongly. The study further indicated that ginkgo may influence brain activity, altering glucose metabolism in regions associated with balance and coordination. This suggests that ginkgo could support recovery following acute vestibular loss, encouraging us to consider its potential at higher dosages for vestibular compensation.
Read More
User Reviews
USERS' SCORE
Good
Based on 11 Reviews
8
- All Reviews
- Positive Reviews
- Negative Reviews
9
Reduced dizziness
9 people found this helpful
Great for vertigo! My husband recently had his first (and hopefully last) vertigo attack, which landed him in the hospital. Being anti-medication, I researched natural supplements. I ordered Ginkgo Biloba and Ginger from NOW brand, as I trust them. He has been taking it daily for two weeks, and the dizziness has started to subside after a few days. This will now be part of his daily vitamin regimen.
Read More
9
Immediate vertigo relief
2 people found this helpful
I assure you this product is one of the best and provides immediate relief from inner ear vertigo and migraine pain while enhancing focus. I recommend it for both adults and children.
Read More
9
Stopped vertigo episodes
Since I started taking ginkgo daily, I no longer experience episodes of vertigo. It's been nine months now, and I highly recommend it.
Read More
9
Long-lasting effects
I will repurchase! This is among several vitamins I take for vertigo. Purchasing all the included vitamins was cheaper than just the lipo-flavonoid alone, and the effects are significantly better and last longer. I haven't had a spell in months.
Read More
6
Improved blood circulation
22 people found this helpful
This excellent Ginkgo-Gotu Kola-Siberian Ginseng formula works brilliantly to improve blood circulation to the brain, which is beneficial for treating vertigo. It may lower blood pressure, making it suitable for those with high blood pressure. With Siberian ginseng included, this product helps the body adapt to a healthy blood pressure. It's perfect for anyone living a stressful lifestyle and experiencing mental strain.
Read More
Frequently Asked Questions
9
Immediate vertigo relief
2 people found this helpful
I assure you this product is one of the best and provides immediate relief from inner ear vertigo and migraine pain while enhancing focus. I recommend it for both adults and children.
9
Stopped vertigo episodes
Since I started taking ginkgo daily, I no longer experience episodes of vertigo. It's been nine months now, and I highly recommend it.
7.5
Dizziness decreased
I have vertigo associated with IHD and take one capsule before breakfast. A few days after starting this product, my dizziness significantly decreased.
9
Long-lasting effects
I will repurchase! This is among several vitamins I take for vertigo. Purchasing all the included vitamins was cheaper than just the lipo-flavonoid alone, and the effects are significantly better and last longer. I haven't had a spell in months.
6
Improved blood circulation
22 people found this helpful
This excellent Ginkgo-Gotu Kola-Siberian Ginseng formula works brilliantly to improve blood circulation to the brain, which is beneficial for treating vertigo. It may lower blood pressure, making it suitable for those with high blood pressure. With Siberian ginseng included, this product helps the body adapt to a healthy blood pressure. It's perfect for anyone living a stressful lifestyle and experiencing mental strain.
7.5
Reduced ear ringing
My wife suffered from vertigo and stress, which caused her to experience ringing in her ears. Thankfully, this product has helped significantly.
8
We explored how flunarizine, when combined with ginkgo leaf extract and dipyridamole injection, can impact hemorheology and improve symptoms of vertigo in elderly patients. The study involved 105 elderly participants with vertigo, dividing them into two groups: one receiving the combination treatment and the other receiving flunarizine alone.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
9
We conducted a robust study to evaluate how effective Ginkgo biloba extract, known as GBE50, is for treating dizziness related to cerebral arteriosclerosis. This involved a well-structured multi-center trial that was double-blind and randomized. We gathered 404 participants across ten hospitals in China, allowing us to compare results thoroughly.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
4
Ginkgo shows no significant benefits
We conducted a study to understand the effectiveness of methylprednisolone and Ginkgo biloba in treating vestibular neuritis, a condition that causes vertigo. In our trial, we grouped patients into two sets: one group received the steroid treatment, while the other group did not. Both groups, however, continued with regular vestibular exercises and were given Ginkgo biloba as part of their treatment plan.
Throughout the study, we measured different aspects of vestibular function using various tests. We also evaluated patients' dizziness levels through a handicap index. Notably, while both groups showed improvement over time, there were no significant differences between those who received methylprednisolone and those who did not.
Our findings indicated that Ginkgo biloba, in conjunction with other treatments, did not lead to marked additional benefits in reducing vertigo symptoms. Overall, this comprehensive assessment revealed that while Ginkgo has its uses, it does not significantly enhance recovery in vestibular neuritis patients who are already undergoing vestibular exercises.
Throughout the study, we measured different aspects of vestibular function using various tests. We also evaluated patients' dizziness levels through a handicap index. Notably, while both groups showed improvement over time, there were no significant differences between those who received methylprednisolone and those who did not.
Our findings indicated that Ginkgo biloba, in conjunction with other treatments, did not lead to marked additional benefits in reducing vertigo symptoms. Overall, this comprehensive assessment revealed that while Ginkgo has its uses, it does not significantly enhance recovery in vestibular neuritis patients who are already undergoing vestibular exercises.
References
- Liu X, Shu L, Zheng J. Effects of flunarizine combined with ginkgo leaf extract and dipyridamole injection on hemorheology in elderly patients with vertigo. Pak J Med Sci. 2024;40:337. 10.12669/pjms.40.3.8456
- Ma N, Liu H, Liu B, Zhang L, Li B, et al. Effectiveness and acceptance of Vestibulo-Ocular Reflex adaptation training in children with recurrent vertigo with unilateral vestibular dysfunction and normal balance function. Front Neurol. 2022;13:996715. 10.3389/fneur.2022.996715
- Sha RN, Tang L, Du YW, Wu SX, Shi HW, et al. Effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of dizziness caused by cerebral arteriosclerosis: a multi-center, double-blind, randomized controlled trial. J Tradit Chin Med. 2022;42:83.
- Lindner M, Gosewisch A, Eilles E, Branner C, Krämer A, et al. Extract EGb 761 Improves Vestibular Compensation and Modulates Cerebral Vestibular Networks in the Rat. Front Neurol. 2019;10:147. 10.3389/fneur.2019.00147
- Yoo MH, Yang CJ, Kim SA, Park MJ, Ahn JH, et al. Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial. Eur Arch Otorhinolaryngol. 2017;274:2443. 10.1007/s00405-017-4556-1
- Laccourreye O, Werner A, Laccourreye L, Bonfils P. Benefits, pitfalls and risks of phytotherapy in clinical practice in otorhinolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:95. 10.1016/j.anorl.2016.11.001
- Xu Y, Fu M, Zhang N. [Efficacy of different treatment on residual symptoms aftercanalith repositioning procedure in patients withbenign paroxysmal positional vertigo]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30:1146. 10.13201/j.issn.1001-1781.2016.14.015
- Zhang H, Zhang Q, Xu D, Xu M. [Treatment outcome of patients with idiopathic sudden sensorineural hearing loss and concomitant benign paroxysmal positional vertigo]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;28:1212.
- Sokolova L, Hoerr R, Mishchenko T. Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine. Int J Otolaryngol. 2014;2014:682439. 10.1155/2014/682439
- Agus S, Benecke H, Thum C, Strupp M. Clinical and Demographic Features of Vertigo: Findings from the REVERT Registry. Front Neurol. 2013;4:48. 10.3389/fneur.2013.00048
- Zhang H, Geng M, Yan B, Lu X. [Epley's manoeuvre versus Epley's manoeuvre plus labyrinthine sedative in the management of benign paroxysmal positional vertigo: prospective, randomised study]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012;26:750.
- Hamann KF. [Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations]. HNO. 2007;55:258.
- Issing W, Klein P, Weiser M. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J Altern Complement Med. 2005;11:155.
- Orendorz-Fraczkowska K, Pośpiech L, Gawron W. [Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761)]. Otolaryngol Pol. 2002;56:83.
- Clostre F. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. Ann Pharm Fr. 1999;57 Suppl 1:1S8.
- Cesarani A, Meloni F, Alpini D, Barozzi S, Verderio L, et al. Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. Adv Ther. 1998;15:291.
